RESEARCH & EDUCATION LIBRARY
A goal-organized overview of compounds commonly discussed in peptide research. Evidence quality varies widely; human clinical evidence and regulatory status are identified separately from preclinical or experimental findings.
Fat Loss & Metabolic Research
Semaglutide, tirzepatide, retatrutide, survodutide, mazdutide, AOD-9604, MOTS-C, cagrilintide and related metabolic compounds.
Human evidence varies by compoundGrowth Hormone / Body Composition
CJC-1295, ipamorelin, tesamorelin, sermorelin, GHRP compounds, IGF-related compounds and growth-hormone research.
Clinical + investigationalRecovery & Tissue Research
BPC-157, TB-500 / thymosin-beta-4 research, GHK-Cu, KPV, ARA-290, LL-37, SS-31 and related tissue-repair research.
Many uses remain experimentalCognition & Neuroprotection
Semax, Selank, Cerebrolysin, Cortagen, Pinealon and other compounds studied for neurological or cognitive effects.
Evidence/regulation differs by countryLongevity & Cellular Research
Epitalon, NAD+, SS-31, thymosin alpha-1 and experimental senescence/bioregulator research.
Do not equate mechanistic findings with proven longevitySexual Health & Reproductive Research
PT-141/bremelanotide, kisspeptin, oxytocin, gonadorelin and gonadotropin-related research.
Some are prescription therapiesSkin, Hair & Cosmetic Research
GHK-Cu, SNAP-8 and melanocortin-related compounds commonly discussed in aesthetic research.
Route and evidence matterImmune & Inflammation Research
Thymosin alpha-1, KPV, VIP, LL-37 and other immune-signaling compounds.
Medical supervision may be required